Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial

Abstract

Background Corticosteroids have been used to treat head injuries for more than 30 years. In 1997, findings of a systematic review suggested that these drugs reduce risk of death by 1-2%. The CRASH trial--a multicentre international collaboration--aimed to confirm or refute such an effect by recruiting 20000 patients. In May, 2004, the data monitoring committee disclosed the unmasked results to the steering committee, which stopped recruitment. Methods 10008 adults with head injury and a Glasgow coma score (GCS) of 14 or less within 8 h of injury were randomly allocated 48 h infusion of corticosteroids (methylprednisolone) or placebo. Primary outcomes were death within 2 weeks of injury and death or disability at 6 months. Prespecified subgroup analyses were based on injury severity (GCS) at randomisation and on time from injury to randomisation. Analysis was by intention to treat. Effects on outcomes within 2 weeks of randomisation are presented in this report. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN74459797. Findings Compared with placebo, the risk of death from all causes within 2 weeks was higher in the group allocated corticosteroids (1052 [21.1%] vs 893 [17.9%] deaths; relative risk 1.18 [95% CI 1.09-1.27]; p=0.0001). The relative increase in deaths due to corticosteroids did not differ by injury severity (p=0.22) or time since injury (p=0.05). Interpretation Our results show there is no reduction in mortality with…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)17188-2

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 2

  1. Otani, 1994, Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury [Japanese], Sekitsui Sekizui J, 7, 633
  2. Bracken, 1999, Pharmacological interventions for acute spinal cord injury (Cochrane Review)

Cited by

See all 1,111

Metadata

Authors
Roberts, I., Yates, D., Sandercock, P. A., Farrell, B., Wasserberg, J., Lomas, G., Cottingham, R., Svoboda, P., Brayley, N., Mazairac, G., Laloë, V., Muñoz-Sánchez, A., Arango, M. F., Hartzenberg, B. H., Khamis, H., Yutthakasemsunt, S., Komolafe, E., Olldashi, F., Yadav, Y., Murillo-Cabezas, F., Shakur‐Still, H., & Edwards, P. J.
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-10
Volume
364
Issue
9442
Pages
1321-1328
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2340669326
Cited by
1,111
References
21
Citations by year
2026: 35 · 2025: 37 · 2024: 51 · 2023: 51 · 2022: 47 · 2021: 45 · 2020: 63 · 2019: 56 · 2018: 54 · 2017: 60 · 2016: 49 · 2015: 54 · 2014: 54 · 2013: 57 · 2012: 49
FWCI
35.44
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
Medical Research Council
Topics
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Emergency Medicine › Trauma and Emergency Care Studies
Keywords
intravenous corticosteroids, methylprednisolone, traumatic brain injury, mortality, Glasgow Coma Scale, CRASH trial, corticosteroid adverse effects
MeSH terms
Adolescent, Adult, Double-Blind Method, Female, Glucocorticoids, Craniocerebral Trauma, Humans, Infusions, Intravenous, Male, Methylprednisolone, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Glasgow Coma Scale, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)17188-2
The paper
Roberts, I., Yates, D., Sandercock, P. A., Farrell, B., Wasserberg, J., Lomas, G., Cottingham, R., Svoboda, P., Brayley, N., Mazairac, G., Laloë, V., Muñoz-Sánchez, A., Arango, M. F., Hartzenberg, B. H., Khamis, H., Yutthakasemsunt, S., Komolafe, E., Olldashi, F., Yadav, Y., . . . Edwards, P. J. (2004). Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)17188-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.